Past two years Past Year Past 30 Days
Abstract Views 214 75 0
Full Text Views 9 1 0
PDF Downloads 5 2 0
 
 
 
 
 
 
 
 
 
 
 

Amodiaquine Resistant Falciparum Malaria in Thailand

A. P. HallU.S. Army Medical Component, SEATO Medical Research Laboratories, Trad Provincial Hospital, Bangkok, Thailand, Thailand

Search for other papers by A. P. Hall in
Current site
Google Scholar
PubMed
Close
,
H. E. SegalU.S. Army Medical Component, SEATO Medical Research Laboratories, Trad Provincial Hospital, Bangkok, Thailand, Thailand

Search for other papers by H. E. Segal in
Current site
Google Scholar
PubMed
Close
,
E. J. PearlmanU.S. Army Medical Component, SEATO Medical Research Laboratories, Trad Provincial Hospital, Bangkok, Thailand, Thailand

Search for other papers by E. J. Pearlman in
Current site
Google Scholar
PubMed
Close
,
P. PhintuyothinU.S. Army Medical Component, SEATO Medical Research Laboratories, Trad Provincial Hospital, Bangkok, Thailand, Thailand

Search for other papers by P. Phintuyothin in
Current site
Google Scholar
PubMed
Close
, and
S. KosakalU.S. Army Medical Component, SEATO Medical Research Laboratories, Trad Provincial Hospital, Bangkok, Thailand, Thailand

Search for other papers by S. Kosakal in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Amodiaquine cured 38% (13/34) of patients with falciparum malaria in Southeast Thailand. Chloroquine cured 0% (0/13). The cure rates with amodiaquine were the same whether a 1.5 g or 2.0 g course was used. Most patients were resistant to amodiaquine at the RI level and to chloroquine at the RII level. In hospital, amodiaquine cleared parasitemia more frequently than did chloroquine. With the 2.0 g course of amodiaquine, the parasite clearance time was 77 hours; the fever clearance time of 36 hours was low and suggests that amodiaquine does not cause a drug fever. Because of resistance, chloroquine should not be used for falciparum malaria in Thailand. Routine use of amodiaquine is not indicated because more effective drugs are available.

Author Notes

Present address: Division of Preventive Medicine, Walter Reed Army Institute of Research, Washington, D.C. 20012.

Save